Latest Market Research Updates

Enteric Disease Testing Market Is Projected To Reach $4.2 Billion By 2025

San Francisco, 03 Oct 2019 - The global enteric disease testing market is expected to reach USD 4.2 billion by 2025 according to a new study by Grand View Research Inc. Increasing demand for rapid diagnosis in order to treat diseases such as cholera, and other diarrheal diseases, rise in the aging population accompanied with unhygienic living conditions and growing application of medical testing for enteric diseases are expected to drive the market over the forecast period.

The growth is further attributed to rising healthcare expenditure, supportive government initiatives, and augmenting disease prevalence rate.Economic and environmental factors such as poor sanitation and rising population living below the poverty line with no access to hygienic food and water supply are attributed to growing incidence rate of the infections and thus propel the market growth.

According to database of Bill and Melinda Gate Foundation, enteric diseases were responsible for about 500,000 deaths each year and these are anticipated to increase further. The highest mortality rate was observed amongst people above 75 years of age followed by children under 5 year of age.

Strategic initiatives by healthcare federal bodies such as the WHO and UNICEF, to manage the disease fatality effectively are expected to assist market growth. These agencies are working towards promoting widespread testing of people for such infections by conducting awareness programmes and healthcare camps. They also fund local agencies in third world countries to limit the spread of these infections.

Explore Complete Report: http://www.grandviewresearch.com/industry-analysis/enteric-disease-testing-market

Further key findings from the study suggest:

Bacterial enteric disease testing market is expected to dominate the market in 2025 with revenue share of over 60.32% in 2016 due to higher occurrence of these infections. According to research conducted by Johns Hopkins Bloomberg School of Public Health, around four to six million people die annually due to bacterial infection induced diarrhea.
Parasitic enteric disease testing market is expected to register significant growth with CAGR of 1.9%. The WHO has estimated over 200 million people to be infected annually by parasites such as giardia lamblia, cryptosporidium and E. histolytica.
North American region is anticipated to contribute for 26.55% revenue in 2025, owing to rising geriatric population base, increasing number of immigrants, and rising patient awareness levels coupled with relatively higher healthcare expenditures in the region.
Asia Pacific region is projected to reach over USD 1.0 billion by registering lucrative growth rate in 2025. Government efforts in countries such as Japan, China, and India to increase awareness and promote higher testing are expected to drive the market over the forecast period.
Major market players are Alere Inc., Quest Diagnostics, Becton Dickinson & Company, bioMerieux, Bio-Rad Laboratories and Cepheid.
Industry players are constantly fueling the market with new product launches or upgrading the existing technology. In January 2015, Biomerica filed a patent application with the U.S. Patent and Trademark Office for a test used in detection of gastrointestinal disorder.
Apart from technology innovation, many industry players are collaborating to use each other’s strength and are formulating strategic alliances in order to incur higher profits. For instance, in May 2017, Quest diagnostics announced collaboration with PeaceHealth to enhance the service through high value design and innovation.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For More Information: www.grandviewresearch.com

Medical Document Management System Market Worth $0.63 Billion By 2025

San Francisco, 03 Oct 2019 - The global medical document management systems market size is expected to reach USD 0.63 billion by 2025, according to a new report by Grand View Research, Inc. The global market is estimated to register a CAGR of 10.2% during the forecast period. The sector has experienced noticeable growth in the past few years owing to rising burden of paper management and storage.

Medical document management solutions such as hospital information systems, patient monitoring system, Electronic Medical Record (EMR), and e-prescribing methods facilitate managing medical records like insurance cards/claims, admission forms, invoices, and records of laboratory results. Rising need for ease of managing large amounts of healthcare data along with increasing demand for Electronic Health Record (EHR) and Clinical Trial Management System (CTMS) is expected to propel market demand.

Various government initiatives to develop healthcare IT and clinical document managing software sector globally are the key drivers of the market. For instance, the 58th World Health Assembly; where the WHO urged member states to promote EHR and health documentation and create awareness regarding the same. Apart from this, there are many region-specific initiatives that are promoting the adoption of these services. For instance, the Health Department Republic of South Africa set guidelines for healthcare IT strategy in the region.

Explore Complete Report: https://www.grandviewresearch.com/industry-analysis/medical-document-management-systems-market

Further key findings from the study suggest:

Need for creating paperless environment while reducing manual errors is expected to drive market growth
Cloud-based system is anticipated to be the fastest-growing segment over the forecast period owing to low cost of installation, implementation, and set up of these systems
Hospitals and clinics led the end-user segment with the highest revenue share. Increasing number of hospital admissions is driving the demand for medical document management systems
North America is the largest revenue-generating geography followed by Europe. This growth is attributed to the presence of highly-developed healthcare infrastructure and well-defined regulatory frameworks
Asia Pacific is expected to be the fastest-growing regional market over the forecast period. Increasing government initiatives such as implementation of e-Health, huge funding for the development of infrastructure and healthcare IT would fuel the market growth in the near future
Key players in the market are 3M Company; Allscripts Healthcare Solutions, Inc.; Athena Health Inc.; Cerner Corporation; Siemens AG; and GE Healthcare
Several other private companies in the market are EPIC Systems Corporation; NextGen Healthcare Information Systems; and Kofax Ltd.

About Grand View Research

Rat Model Market Worth Scope Of $845.0 Million By 2025

San Francisco, 03 Oct 2019 - The global rat model market is expected to reach USD 845.0 million by 2025, according to a new report by Grand View Research, Inc. As of 2016, outbred type of rat model is commonly utilized for research and educational activities within the healthcare domain. However, advancement in production technologies is expected to boost growth of knockout and conditioned rats.

The production technologies for aforementioned type of model are recent in nature and can be traced back to 2008, post the development of mobile DNA technology. The first knockout model was introduced in 2009 using Zinc Finger Nuclease (ZFN) method, which led to an advancement in the field of rat models. Other tools for genetic editing are Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), homologous recombination, and N-ethyl-N-nitrosourea (ENU) mutagenesis.

Furthermore, supportive infrastructure and technology coupled with growing incidence of chronic conditions & genetic mutation amongst human species are expected to extend higher applicability for research purposes, thereby boosting growth.

Explore Complete Report: http://www.grandviewresearch.com/industry-analysis/rat-model-market

Further key findings from the study suggest:

Outbred is expected to dominate the type segment for rat model market. Presence of numerous outbred type and higher applicability of these to mimic human diseases is anticipated to support growth over the forecast period.
Microinjection is anticipated to witness the fastest growth over the forecast period owing to faster development of the models and reduction in breeding time. Similarly, development of newer technology within the other segment is expected to propel growth.
Based on services, the rat model market is predicted to witness higher revenue contribution by breeding process. Cryopreservation is anticipated to witness fastest growth over the forecast period.
Rising production of conditioned rats for behavioral studies and growing R&D within neurological application is expected to support lucrative growth of rat model. Other application expected to support growth include cardiovascular disorders, diabetes, obesity, and renal disorders.
The key market players of the industry include Covance Inc.; Envigo; Charles River Laboratories International, Inc.; Horizon Discovery Group plc.; TransViragen, Inc.; Javier Labs; and others. Mergers & acquisitions are expected to strengthen company capabilities. For instance, Horizon Discovery Group plc. accomplished the aforementioned goal by acquiring SAGE Labs, Inc. in 2014.

About Grand View Research

Digital Pathology Market Worth Scope Of $1.67 Billion by 2026

San Francisco, 01 Oct 2019 - The global digital pathology market size is expected to reach USD 1.67 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 11.7% during the forecast period. Increasing prevalence of chronic diseases triggers the demand for advanced diagnostics, which is expected to drive the market growth. Growing economic stability and awareness pertaining to the benefits with the use of computer-aided diagnostics is further contributing to the growth.

Technological advancements such as digital imaging, computerization, robotic light microscopy, and multiple fiberoptic communications are some of the key factors driving the adoption of digital pathology. In addition, introduction of cloud-based technology enabling storage of digital slides coupled with secure access to pathologists is expected to serve as a potential growth driver for the market.

Digital pathology has important role in companion diagnostics and drug development pipeline, including molecular biology, biobanking, molecular tissue profiling, and tissue microarray analysis. Increasing demand for high-quality tissue samples in tissue-based biomarker research is expected to propel adoption of the technology over the forecast period.

The market is expected to witness intense competition in near future owing to rising adoption of rigorous strategies by the market players to sustain competition. For instance; whole slide imaging system manufacturers focus on obtaining premarket approval for diagnostic digital systems to capture greater revenue share.

Access In-depth Insight: https://www.grandviewresearch.com/industry-analysis/digital-pathology-systems-market

Further key findings from the study suggest:

Devices held the dominant market share in 2018 owing to increased use in academic research
Rising implementation of slide management system in stratified medicine and tissue-based biomarker research is one of the key contributing factors for the dominance of this technology
Software segment is expected to witness lucrative growth in near future as the product assists in faster diagnosis and synchronization of patient data, where healthcare professionals can remotely access this information
Digital pathology is increasingly used in academic research owing to various benefits such as cost-effectiveness and rapid results
Disease diagnosis segment is expected to witness lucrative growth over the forecast period owing to the increasing prevalence of cancer and demand for noble diagnosis techniques
Availability of unified platforms for workflows in pathology is anticipated to boost the usage of computer-aided imaging technology in academic research, which is anticipated to boost the segment growth
Hospital led the end use segment in 2018 owing to the increasing adoption of these technologies across these facilities

About Grand View Research

Contact:Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For More Information: www.grandviewresearch.com

Fetal And Neonatal Care Equipment Market Is Projected To Reach $10.6 Billion By 2026

San Francisco, 01 Oct 2019 - The global fetal (labor & delivery) and neonatal care equipment market size is expected to reach USD 10.6 billion by 2026, based on a new report by Grand View Research, Inc. Fetal and neonatal care devices consist of a variety of equipment that are designed to monitor and detect complications in newborn babies. The market growth can be attributed to factors such as a growing birthrate in developing countries coupled with rising prevalence of associated premature births also known as preemies.

Furthermore, neonatal hospital-acquired infections such as Central Line-Associated Bloodstream Infections (CLABSI) and healthcare-associated pneumonia are additional notable factors responsible for the market growth. Various aspects such as delayed maternal age, induced fertility, and lack of proper prenatal care are considered to be major factors contributing to the birth of premature babies.

According to the WHO estimates, 15 million neonates are born annually and a million were reported to die from preterm birth complications in 2015. To address the complications associated with babies born prematurely, the demand for fetal and neonatal care equipment is expected to rise significantly. In addition, consequences of supportive government policies coupled with rapid technological advancements in modern fetal and neonatal medical equipment is expected to contribute for growth in the long term.

Access Complete Insight Report: https://www.grandviewresearch.com/industry-analysis/fetal-labor-and-delivery-and-neonatal-equipment-market

Further Key Findings from the Study Suggest:

Fetal care equipment accounted for the largest share of the market in 2018, however neonatal care equipment is expected to grow at a rapid rate during the forecast period.
Increasing complications during birth, increasing number of separate facilities for fetal & newborn care, and technological advancement in the fetal & neonatal care field are the key driving factors of the market. For instance, in February 2019, the University of Chicago Medicine launched Fetal and Neonatal Care Center (FNCC). The center offers one stop access to various specialists.
North America held the largest share in the fetal and neonatal care equipment market in 2018 due to the high awareness about neonatal and fetal care along with large number of neonatal intensive care unit (NICU) admissions.
The Asia Pacific region is projected to grow at the highest rate during the forecast period owing to aspects such as high birth rate in some Asia Pacific countries such as India & China and rising awareness programs for the improvement of fetal care & neonatal care.
In July 2013, largest Neonatal Intensive Care Unit in Southeast Asia became operational in Singapore. The facility is equipped with advanced equipment and technology.
The major players operating in the global fetal and neonatal care equipment market include Becton, Dickinson and Company, GE Healthcare, Koninklijke Philips N.V, THE DRAGER GROUP, Natus Medical Incorporated, Masimo Corporation, and Medtronic.
Mergers & collaborations and product development are the key strategies being undertaken by the market players. For instance, in June 2019 Clinical Computer Systems, Inc. entered into an agreement with Huntleigh Healthcare Limited to commercialize OBIX BeCA, a fetal monitor, in the U.S.

About Grand View Research

Clinical Trials Market Size Worth $68.9 Billion By 2026 | Top Companies Are River Laboratories, ICON plc.

San Francisco, 01 Oct 2019 - The global clinical trials market size is expected to reach USD 68.9 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 5.7% during the forecast period. Key drivers impacting the market growth are globalization of clinical trials, development of new treatments such as personalized medicine, augmenting evolution in technology, and rising demand for CROs to conduct clinical trials.

Globalization has led to increase in investment in new product development in emerging countries thereby, positively impacting the market. The availability of the vast array of services from drug discovery to post-marketing surveillance has further simplified the life for mid-size and small-scale pharmaceutical and biotechnological organizations by providing them the option to outsource what they think is beyond their core expertise. For instance, Pfizer currently has three CROs working with it to enhance its product portfolio and drive innovation. According to the partnership agreement with ICON in 2011, Pfizer would only preserve the scientific ownership for the trials and studies conducted by ICON, hence allowing the company to focus and further develop its capabilities in clinical trial designing.

Growing prevalence of disease and new disease cases is expected to give further boost to the clinical trial market. Worldwide population has varied disease profile with emerging countries having the most diverse disease profile. This is expected to boost the clinical trials of new or rare diseases which otherwise would not have found any sponsors. More number of patients having a specific disease would act as a stimulus for biopharmaceutical companies to invest more in clinical trials for a disease segment.

Access In-depth Insights: https://www.grandviewresearch.com/industry-analysis/global-clinical-trials-market

Further key findings from the report suggest:

The market is expected to be dominated by Phase III as of 2018, with Phase I anticipated to witness the fastest growth
Increasing innovation and evolution of treatment is predicted to contribute towards growth of the expanded access trials segment
Based on indication, the oncology segment is anticipated to witness the fastest growth. According to various sources, more than USD 38.0 billion is currently being spent by the healthcare industry towards preclinical and clinical development of oncology therapy products
North America led the overall clinical trials market in terms of revenue share in 2015 owing to the presence of big outsourcing firms and increasing R&D in the region
Key players including Quintiles IMS, Paraxel International Corporation, Charles River Laboratories, ICON plc, SGS SA among the others lead the global clinical trials market.

About Grand View Research

Cardiac Prosthetic Device Market Total Value Would Be $8.7 Billion By 2025

San Francisco, 01 Oct 2019 - The global cardiac prosthetic device market is expected to be over USD 8.7 billion by 2025, based on a new study by Grand View Research, Inc. Rising demand for minimally invasive devices has provided greater growth prospects for the market. New product development through technological advancements is anticipated to foster market growth. The major companies are focusing on expanding their product life and safety benefits of the cardiac prosthetic devices. Such initiatives undertaken by the key players have resulted in increasing survival rates and low stroke rates for transcatheter aortic valves.

Transcatheter Aortic Valve Replacement (TAVR) is covered by Evidence Development (CED) Coverage provided by the Centers for Medicare & Medicaid Services (CMS). Cardiac pacemakers are also covered under Medicare program. Initiatives for reimbursement from the government for such devices are anticipated to boost the demand for cardiac prosthetic devices.

Access Full Insight Report: http://www.grandviewresearch.com/industry-analysis/cardiac-prosthetic-devices-market

Further Key Findings From the Study Suggest:

Heart valve segment was one of the largest segments in 2015 owing to rising prevalence of valvular disease and heart valve failure.
Pacemakers segment is expected to grow significantly, owing to rising reimbursement policies for pacemaker-related surgeries.
Mechanical heart valve segment contributed toward the one of the largest market share in 2015 owing to its increasing product longevity. Moreover, they provide better hemodynamic efficiency. Since mechanical valves are made up of strong durable materials, such as titanium and carbon, they are preferred over other cardiac prosthetic devices.
Transcatheter valve is expected to exhibit lucrative CAGR over the forecast period. TAVR has shown improved patient survival rate as compared to medical therapy. In the past years, it has evolved as a minimally invasive alternative treatment for surgical valve replacement.
Implantable pacemakers are one of the highest revenue generating segments owing to their greater applicability pertaining to heart failure (HF) and other cardiovascular diseases like stroke.
North America contributed toward the largest market share of around 40.0% in 2015. This is primarily due to the fact that the number of pacemaker implantations has increased amongst the Americans over the past two decades. Moreover, companies are focusing on commercial availability of technologically advanced devices in the U.S.
Asia Pacific is anticipated to witness highest CAGR over the forecast period owing to the growing geriatric population in Japan. In 2015, the geriatric population base accounted for around 27% in Japan.
Some key companies in this market are Medtronic, Inc.; St. Jude Medical, Inc.; Boston Scientific Corporation; Edwards Lifesciences Corporation; Abbott Vascular; Siemens Healthcare GmbH; and Sorin Group.
New product development through introduction of advanced technology and mergers & acquisitions are some of the key strategies adopted by the companies to enhance the demand for cardiac prosthetic devices. For instance, in 2015, St. Jude Medical and Thoratec, a company that specializes in mechanical circulatory support technology for the treatment of advanced HF, entered into a definitive agreement aiming at acquisition of the outstanding shares of Thoratec.

About Grand View Research

Latest Market Research Updates

Enteric Disease Testing Market Is Projected To Reach $4.2 Billion By 2025

Medical Document Management System Market Worth $0.63 Billion By 2025

Rat Model Market Worth Scope Of $845.0 Million By 2025

Digital Pathology Market Worth Scope Of $1.67 Billion by 2026

Fetal And Neonatal Care Equipment Market Is Projected To Reach $10.6 Billion By 2026

Clinical Trials Market Size Worth $68.9 Billion By 2026 | Top Companies Are River Laboratories, ICON plc.

Cardiac Prosthetic Device Market Total Value Would Be $8.7 Billion By 2025

mHealth Apps Market Is Projected To Reach $236.0 Billion By 2026

Report Abuse

Labels